Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10034189 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1MAPTMEN1 | |
| SCHEMBL10034160 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL2601475 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL2601482 | 0.92 | — | — | |
| SCHEMBL2601509 | 0.92 | L3MBTL1 (0.37) | KDM4EATML3MBTL1MAPTMEN1 | |
| SCHEMBL10034183 | 0.92 | L3MBTL1 (0.37) | KDM4EATML3MBTL1MAPTMEN1 | |
| SCHEMBL10034203 | 0.92 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL10034214 | 0.89 | KDM4E (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL2601512 | 0.89 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL14330593 | 0.89 | DYRK1A (0.37) | DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546793-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-10-01 | — | — | US | disclosed |
| US-8546793-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-10-01 | — | — | US | disclosed |
| EP-2448035-A2 | Organic light-emitting device | Samsung Mobile Display Co., Ltd. (KR) | 2012-05-02 | — | — | EP | disclosed |
| US-20120097925-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
| US-20120097925-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120097925-A1 | ORGANIC LIGHT-EMITTING DEVICE | AR, NR2E3, CRY1 | KDM4E 3119/4885ATM 1184/4885L3MBTL1 417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.